臨床研究・基礎研究
2010 2009 2008 2007 2006 2005
2004 2003 2002 2001 2000 1999
1998 1997 1996 1995 1994 1993
1992 1991 1990 1989 1988 1987

2019

Koh S, Nakamae H, Nanno S, Nakane T, Nakashima Y, Koh H, Nakamae M, Hirose A, Hino M.
　Mosquito allergy: a novel strong prognostic symptom of outcome after allogeneic hematopoietic transplantation.

Sakatoku K, Takeoka Y, Miura A, Araki T, Fujitani Y, Yamamura R, Nakamae H, Ohta K, Hino M.
　Combination of Frailty Status and Comorbidity Score Improves the Stratification of Survival in Patients With Myelodysplastic Syndrome Owing to Good Predictive Capability for Infection-related Mortality

Nakane T, Okamura H, Tagaito Y, Koh S, Yoshimura T, Makuuchi Y, Nanno S, Nakamae M, Hirose A, Nakashima Y, Koh H, Hino M, Nakamae H
　Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.

Nakamae H, Fujii K, Nanno S, Okamura H, Nakane T, Koh H, Nakashima Y, Nakamae M, Hirose A, Teshima T, Hino M
　A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.

高桑輝人、荒木 拓, 三浦 晃子, 藤谷 洋太朗, 武岡 康信, 太田 健介, 山村 亮介
　再発・難治性多発性骨髄腫に対するイキサゾミブ、レナリドミド、デキサメタゾン併用療法の有効性と安全性の検討

癌と化学療法 46(6)1043-1047

Nishimoto M, Hirose A, Koh H, Nakamae M, Nanno S, Okamura H, Nakane T, Nakashima Y, Hino M, Nakamae H
　Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Okamura H, Koh H, Takakuwa T, Ido K, Makuuchi Y, Ine S, Nanno S, Nakashima Y, Nakane T, Jogo A, Yamamoto A, Hamuro M, Kotani K, Kawabe J, Higashiyama S, Yoshida A, Shiomi S, Ohsawa M, Hino M, Nakamae H
　A noninvasive diagnostic approach using per-rectal portal scintigraphy for sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation

Takakuwa T, Nakashima Y, Koh H, Nakane T, Nakamae H, Hino M
　Short-Term Fasting Induces Cell Cycle Arrest in Immature Hematopoietic Cells and Increases the Number of Naïve T Cells in the Bone Marrow of Mice

Inose R, Takahashi K, Nanno S, Hino M, Nagayama K
　Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy

Ido K, Nakamae M, Koh H, Okamura H, Nanno S, Nishimoto M, Takeoka Y, Hirose A, Nakashima Y, Hashimoto Y, Nakane T, Hino M, Nakamae H
　The Proportional Relationship between Pre-transplant WT1 mRNA Levels and Risk of Mortality after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Not in Remission

 

2018

藤井 一貴, 中前 美佳, 今井 重良, 久保田 浩, 藤岡 一也, 上田 香織, 小宮山 豊, 内田 啓子, 三杉 卓也, 古山 将康, 日野 雅之
　産科大量出血2症例における2社のFDP・D-ダイマー及びその比と線溶分子マーカーの推移について

日本検査血液学会雑誌 2018, 19(3), 328-334

Hashimoto Y, Nakamae H, Tanaka T, Omura H, Horiuchi M, Yoshimura T, Takakuwa T, Mugitani A, Hirose A, Nakamae M, Koh H, Hino M
　Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia.

Koh H, Nanno S, Hino M, Nakamae H
　Diagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues.

 

2017

Koh H, Nanno S, Hino M, Nakamae H
　Diagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues.

Kasashima H, Yashiro M, Nakamae H, Masuda G, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Nakane T, Hino M, Hirakawa K, Ohira M.
　Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.

Nakane T, Nakamae M, Koh H, Nishimoto M, Nakashima Y, Hirose A, Hino M, Nakamae H..
　Autonomic Nervous System Pretransplant Malfunction is a Powerful Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation.

Nishimoto M, Koh H, Tokuwame A, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Koh S, Yoshimura T, Nanno S, Nakamae M, Hirose A, Nakashima Y, Nakane T, Hino M, Nakamae H.
　Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic hematopoietic cell transplantation.

Koh H, Nanno S, Katayama T, Hirose A, Nakamae M, Hino M, Nakamae H..
　Diagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies.

Nanno S, Koh H, Nakashima Y, Katayama T, Okamura H, Koh S, Yoshimura T, Nishimoto M, Hayashi Y, Nakamae M, Hirose A, Nakane T, Hino M, Nakamae H.
　Diagnostic value of serum ferritin and the risk factors and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation.

 

2016

Nanno S, Koh H, Nakashima Y, Katayama T, Okamura H, Koh S, Yoshimura T, Nishimoto M, Hayashi Y, Nakamae M, Hirose A, Nakane T, Hino M, Nakamae H.
　Diagnostic value of serum ferritin and the risk factors and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation.

Nagasaki J, Aoyama Y, Hino M, Ido K, Ichihara H, Manabe M, Ohta T, Mugitani A.
　Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome.

Koh H, Aimoto M, Matsuhisa A, Inoue SI, Katayama T, Okamura H, Yoshimura T, Koh S, Nanno S, Nishimoto M, Nakashima Y, Hirose A, Nakamae M, Nakane T, Hino M, Nakamae H
　Combinational approach using in situ hybridization targeting 23S ribosomal RNA genes and blood cultures for bacterial identification in patients with neutropenia and fever.

Koh S, Koh H, Nakashima Y, Katayama T, Sakabe M, Okamura H, Yoshimura T, Nanno S, Nishimoto M, Hayashi Y, Nakane T, Nakamae H, Ohsawa M, Hino M
　Plasma Kinetics of Th1, Th2 and Th17 Cytokines in Polymyositis Related to Chronic Graft-versus-Host Disease.

Nanno S, Koh H, Katayama T, Hashiba M, Sato A, Makuuchi Y, Nagasaki J, Kuno M, Yoshimura T, Okamura H, Nishimoto M, Hirose A, Nakamae M, Nakane T, Hino M, Nakamae H.
　Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies

Takeoka Y, Sakatoku K, Miura A, Yamamura R, Araki T, Seura H, Okamura T, Koh H, Nakamae H, Hino M, Ohta K
　Prognostic Effect of Low Subcutaneous Adipose Tissue on Survival Outcome in Patients With Multiple Myeloma..

Koh H, Aimoto M, Katayama T, Hashiba M, Sato A, Kuno M, Makuuchi Y, Takakuwa T, Okamura H, Hirose A, Nakamae M, Hino M, Nakamae H
　Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.

Nakamae M, Yamashita M, Koh H, Nishimoto M, Hayashi Y, Nakane T, Nakashima Y, Hirose A, Hino M, Nakamae H
　Lung function score including a parameter of small airway disease as a highly predictive indicator of survival after allogeneic hematopoietic cell transplantation

Yoshida M, Nakao T, Horiuchi M, Ueda H, Hagihara K, Kanashima H, Inoue T, Sakamoto E, Hirai M, Koh H, Nakane T, Hino M, Yamane T
　Analysis of elderly patients with diffuse large B-cell lymphoma: Aggressive therapy is a reasonable approach for "unfit" patients classified by comprehensive geriatric assessment

2015

Nishimoto M, Koh H, Hirose A, Nakamae M, Nakane T, Hayashi Y, Okamura H, Yoshimura T, Koh S, Nanno S, Nakashima Y, Takeshita T, Yamamoto A, Sakai Y, Nishida N, Matsuoka T, Miki Y, Hino M, Nakamae H.
　Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graft-versus-host disease.

Nakamae H, Koh H, Katayama T, Nishimoto M, Hayashi Y, Nakashima Y, Nakane T, Nakamae M, Hirose A, Hino M.
　HLA haplo-identical peripheral blood stem cell transplantation using reduced dose of post-transplantation cyclophosphamide for poor prognosis or refractory leukemia and myelodysplastic syndrome.

Koh S, Yamada K, Nishimoto M, Hayashi Y, Koh H, Nakashima Y, Nakane T, Hirose A, Nakamae M, Kakeya H, Hino M, Nakamae H
　Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.

Nishimoto M, Nakamae H, Koh H, Nakamae M, Hirose A, Hayashi Y, Nakashima Y, Nakane T, Hino M.
　Response-guided therapy for steroid-refractory acute GVHD starting with very-low-dose anti-thymocyte globulinl

 

2014

Nakamae M, Nakamae H, Koh S, Koh H, Nishimoto M, Nakashima Y, Nakane T, Hirose A, Hino M.
　Prognostic Value and Clinical Implication of Serum Ferritin Levels following Allogeneic Hematopoietic Cell Transplantation

Aimoto M, Koh H, Katayama T, Okamura H, Yoshimura T, Koh S, Nanno S, Nishimoto M, Hirose A, Nakamae M, Nakane T, Nakamae H, Kakeya H, Hino M.
　Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.

Nishimoto M, Nakamae H, Nakamae M, Hirose A, Hagihara K, Koh H, Nakane T, Terada Y, Hino M.
　Feasibility of umbilical cord blood transplantation with a myeloablative, reduced toxicity-conditioning regimen.

 

2013

Yoshimura T, Nakane T, Hirose A, Koh H, Nakamae M, Aimoto M, Nishimoto M, Hayashi Y, Terada Y, Nakamae H, Hino M
　Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.

山村亮介（済生会中津病院）、坂本恵利奈、寺田芳樹、阪本親彦、小坂さおり、青山泰孝、平井　学、太田健介、日野雅之
輸血後鉄過剰症に対する経口鉄キレート剤(deferasirox)の使用経験

日本輸血細胞治療学会誌　2013. 58:770-773

小川吉彦（大阪市立総合医療センター）、吉田全宏、金島　広、中尾隆文、白野倫徳、後藤哲志、福島裕子、井上　健、山根孝久
　当院におけるHIV感染合併非ホジキンリンパ腫の臨床的検討

癌と化学療法 2013; 40:1027-1030

吉田全宏（大阪市立総合医療センター）、金島　広、中尾隆文、小川吉彦、日野雅之、中根孝彦、太田忠信、 久村岳央、間部賢寛、山村亮介、山根孝久
　エルトロンボパグを使用した難治性特発性血小板減少性紫斑病の後方視的検討

臨床血液　2013, 54:;444-450

中前博久、西本光孝、徳和目篤史、日野雅之
　消化管急性移植片対宿主病に対するベクロメタゾンプロピオン酸エステル製剤の有効性

臨床薬理の進歩 2013;93-98

Nishimoto M, Nakamae H, Koh H, Nakane T, Nakamae M, Hirose A, Hagihara K, Nakao Y, Terada Y, Ohsawa M, Hino M
　Risk factors affecting cardiac left-ventricular hypertrophy and systolic and diastolic function in the chronic phase of allogeneic hematopoietic cell transplantation

 

2012

Nishimoto M, Nakamae H, Koh H, Nakane T, Nakamae M, Hirose A, Hagihara K, Nakao Y, Terada Y, Ohsawa M, Hino M
Risk factors affecting cardiac left-ventricular hypertrophy and systolic and diastolic function in the chronic phase of allogeneic hematopoietic cell transplantation

小坂さおり(大阪府済生会中津病院)、山村亮介、康　秀男、稲葉、荒木　拓、藤谷洋太朗、武岡康信、洪 　鉉寿、太田健介.
　初発症候性多発性骨髄腫に対するデキサメタゾン大量療法 先行ボルテゾミブ・デキサメタゾン併用療法の効果.

新薬と臨床 2012;61(6):1734-1742

Nakane T, Nakamae H, Hirose A, Nakamae M, Koh H, Hayashi Y, Nishimoto M, Umemoto Y, Yoshimura T, Bingo M, Okamura H, Yoshida M, Ichihara H, Aimoto M, Terada Y, Nakao Y, Ohsawa M, Hino M.
　Eosinophilia, Regardless of Degree, is Related to Better Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.

Koh H, Nakane T, Sakamoto E, Katayama T, Nakamae H, Ohsawa M, Hino M
　Serum Cytokine Profiles in Hemophagocytic Syndrome following Allogeneic Hematopoietic Stem Cell Transplantation.
小川吉彦（大阪市立総合医療センター）、向井　悟、金島　広、中尾隆文、山根孝久.
　再発・難治性低悪性度B 細胞性非ホジキンリンパ腫に対するbendamustine（トレアキシン）の治療経験.
新薬と臨床 2012;61(6):1271-1275

Hayashi Y, Nakamae H, Katayama T, Nakane T, Koh H, Nakamae M, Hirose A, Hagihara K, Terada Y, Nakao Y, Hino M.
　Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib.

2011

Ichihara H, Nakamae H, Hirose A, Nakane T, Koh H, Hayashi Y, Nishimoto M, Nakamae M, Yoshida M, Bingo M, Okamura H, Aimoto M, Manabe M, Hagihara K, Terada Y, Nakao Y, Hino M.
　Immunoglobulin prophylaxis against cytomegalovirus infection in patients at high risk of infection following allogeneic hematopoietic cell transplantation.

Koh H, Nakamae H, Hagihara K, Nakane T, Manabe M, Hayashi Y, Nishimoto M, Umemoto Y, Nakamae M, Hirose A, Inoue E, Inoue A, Yoshida M, Bingo M, Okamura H, Aimoto R, Aimoto M, Terada Y, Koh KR, Yamane T, Ohsawa M, Hino M
　Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
Nakane T, Nakamae H, Koh H, Nakamae M, Hayashi Y, Nishimoto M, Yoshimura T, Inoue E, Inoue A, Aimoto R, Aimoto M, Terada Y, Koh KR, Yamane T, Hino M
　Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation.
 
2010
Li HZ, Koh K-R, Toramoto T, Nakamae H, Yamane T, Ohta K, Hino M.
　Cytosine-arabinoside stimulates the capability of human marrow stromal cells to support normal hematopoiesis.
Osaka City Med J 2010;56(22):11-20
中前博久、寺田芳樹、中根孝彦、康　秀男、中前美佳、相本　蘭、廣瀬朝生、林　良樹、西本光孝、井上恵里、吉村卓朗、井上敦司、山根孝久、日野雅之
　静注Busulfan（Busulfex）＋Cyclophosiphamide＋Total Lymphoid Irradiationを用いたModified Myeloablative Conditioningによる同種造血幹細胞移植.
Nakane T, Nakamae H, Koh H, Nakamae M, Aimoto R, Terada Y, Koh KR, Yamane T, Hino M
　Heart rate variability during and after peripheral blood stem cell leukapheresis in autulogous transplant patients and allogeneic transplant donors.

2009
をクリックしていただくと和文抄録がごらんいただけます
Terada Y, Nakamae H, Aimoto R, Kanasima H, Sakamoto E, Aimoto M, Inoue E, Koh H, Nakane T, Takeoka Y, Ohsawa M, Koh KR, Yamane T, Nakao Y, Ohta K, Mugitani A, Teshima H, Hino M
　Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma.
Ohta K（大阪府済生会中津病院）, Nishiki-Kosaka S, Nakao Y, Kumura T, Hagihara K, Sakamoto E, Okamoto S, Hirose A, Aoyama Y, Yamamura R, Hayashi Y, Umemoto Y, Terada Y, Takeoka Y, Nakane T, Koh H, Hino M
　Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan.
Nakane T, Nakamae H, Mori T, Yamaguchi H, Kobayashi Y, Amimoto M, Sakamoto E, Terada Y, Nakamae M, Koh K-R, Yamane T, Yoshiyama M, Hino M
　Cadiac and autonomic nerve function after reduced-intensity stem cell transplantation for hematologic malignancy in patients with pre-transplant cardiac dysfunction.

2008
をクリックしていただくと和文抄録がごらんいただけます
Nakane T, Nakamae H, Kamoi H, Koh H, Takeoka Y, Sakamoto E, Kanashima
H, Nakamae M, Ohta K, Terada Y, Koh K-R, Yamane T, Hino M.
　Prognostic value of serum surfactant protein D level prior to transplant for
the development of bronchiolitis obliterans syndrome and idiopathic pneumonia
syndrome following allogeneic hematopoietic stem cell transplantation.

2006
をクリックしていただくと和文抄録がごらんいただけます
Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M
　Risk factor analysis for thrombotic microangiopathy after reduced intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
山根孝久、廣瀬朝生、中嶋康博、中根孝彦、康　秀男、武岡康信、中前美佳、山村亮介、中前博久、中尾吉孝、麥谷安津子、屋木敏也、手島博文、日野雅之
　non-Hodgkin's lymphomaに対する地固め療法としての自家末梢血幹細胞移植併用大量化学療法　-第2報-.
Yamane T, Hagihara K, Nakamae H, Hasegawa T, Hino M.
 T-lymphocyte subset analysis using the automated hematology analyser CELL-DYN 4000 for patients with hematological disorders.

2005
をクリックしていただくと和文抄録がごらんいただけます
Yamane T, Nakamae H, Hasegawa T, Terada Y, Hagihara Y, Ohta K, Hino M
　Cord blood transplantation for adult patients with hematological malignancies.
廣瀬朝生、山根孝久、中嶋康博、間部賢寛、金島　広、萩原潔通、坂本恵利奈、中前美佳、寺田芳樹、小坂さおり、青山泰孝、阪本親彦、久村岳央、高　起良、平井　学、太田健介、中尾吉孝、麥谷安津子、手島博文、日野雅之
　Aggressive B-cell non-Hodgkin's lymphomaに対する自家造血幹細胞移植.
Nakamae H, Tsumura K, Terada Y, Nakane T, Nakamae M, Ohta K, Yamane T, Hino M
　Notable effects of angiotensin II receptor blocker, Valsartan, on acute cardiotoxic changes following standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone..
Hirose A, Yamane T, Shibata H, Kamitani T, Hino M
　Automated analyzer evaluation of reticulocytes in bone marrow and peripheral blood of hematologic disorders.
Nishioka T, Yamane T, Takubo T, Ohta K, Park K, Hino M
　Detection of various platelet-associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura.
柴田仙子、山根孝久、坂本恵利奈、中前博久、太田健介、日野雅之
　発熱性好中球減少症に対する抗菌薬治療の臨床解析.
Hagihara K, Yamane T, Aoyama Y, Nakamae H, Hino M
　Evaluation of the utility of a fully automated hematological analyzer (CELL-DYN4000) for counting CD4+ T helper cells at low concentrations.
Kanashima H, Yamane T, Takubo T, Kaminitani T, Hino M
　Evaluation of noninvasive hemoglobin monitoring for hematological disorders.

2004
Nakamae H, Yamane T, Aoyama Y, Yamamura R, Ohta K, Hino M
　Conditioning regimens including high-dose busulfan cause a high incidence of transplant-related mortality after myeloablative stem cell transplantation.
Nakamae H, Tsumura M, Akahori M, Terada Y, Yamane T, Hayashi T, Saito I, Kaneko M, Okamoto N, Ichihara Y, Ohta K, Hino M
　QT dispersion correlates with systolic rather than diastolic parameters in patients receiving anthracycline treatment.
Shibata H, Yamane T, Hirose A, Kamitani T, Hino M
　Automated analysis of bone marrow reticulocytes using the XE-2100 automated hematology analyzer.
Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K, Hayashi T, Tsumura K
　Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation.
山村亮介、山根孝久、青山泰孝、中前博久、長谷川太郎、太田健介、中尾吉孝、太田忠信、麥谷安津子、日野雅之
　再発・難治性非ホジキンリンパ腫に対するAra-C/CBDCA療法.
中尾吉孝、紙谷富夫、城村尚登、橋本卯巳
　当院における血液疾患患者動向について.
大阪医学 2004;37; 37(3): 16-9

2003
Takubo T, Wakui S, Daigo K, Kurokata K, Ohashi T, Katayama K, Hino M
　Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.
Yamane T, Yamamura R, Aoyama Y, Nakamae H, Hasegawa T, Sakamoto C, Shibata H, Terada Y, Koh G, Hino M
　Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation.
Terada Y, Hato F, Sakamoto C, Hasegawa T, Suzuki K, Nakamae H, Ohta K, Yamane T, Kitagawa S, Hino M
　Thrombopoietin stimulates ex vivo expansion of mature neutrophils in the early stages of differentiation.
中前博久
　ヒト骨髄ストローマ細胞におけるサイトカイン遺伝子の発現：real-time polymerase chain reaction法を用いた定量的解析
大阪市医学会雑誌 2003;52(1-2):37-44
青山泰孝、中前博久、山村亮介、牧田香理、島　悦子、長谷川太郎、阪本親彦、洪　鉉寿、太田健介、山根孝久、田窪孝行、日野雅之
　健常人ドナーにおける高用量G-CSF投与の影響と末梢血造血幹細胞動員および採取効率に関する因子の検討
Akahori M, Nakamae H, Hino M, Yamane T, Hayashi T, Ohta K, Tatsumi N, Kitagawa S, Tsumura K
　Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue.
Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, Higuchi K, Arakawa T
　Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura.
Shibata H, Yamane T, Yamamura R, Ohta K, Takubo T, Kamitani T, Hino M
　Automatic analysis of normal bone marrow blood cells using the XE-2100 automated hematology analyzer.

2002
Takubo T, KanashimaH, Terada Y, ShibataH, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane Y, Hino M, Hashimoto S, Ohta T, Kamitani T, Tatsumi T.
　Clinical application of serum E-cadherin levels: a report in typing of acute leukemias, staging of non-Hodgkin's lymphomas or subtyping of myelodysplastic syndromes.
Medical Postgraduates 2002;40:442-6
Takubo T, Aoyama Y, Nakamae H, Tanaka K, Ohta K, Yamane T, Hino M.
　Combination assay of urinary free L-fucose and trypsin inhibitor may be useful indicators of disease activity in patients with hematologic malignancies.
Takubo T, Kanashima H, Terada Y, Shibata H, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Clinical significance of serum E-selectin levels in patients with various haematologic malignancies.
Takubo T, Kanashima H, Terada Y, Shibata H, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N, Ohshima K.
　E-cadherin expression in lymph nodes of three patients with non-Hodgkin's lymphoma.
Naruse TK, Kawata H, Inoko H, Isshiki G, Yamano K, Hino M, Tatsumi N.
　The HLA-DOB gene displays limited polymorphism with only one amino acid substitution.
Kinoshita Y, Yamane T, Takubo T, Kanashima H, Kamitani T, Tatsumi N, Hino M.
　Measurement of hemoglobin concentrations using the astrim noninvasive blood vessel monitoring apparatus.
Koh KR, Ohta K, Nakamae H, Hino M, Yamane T, Takubo T, Tatsumi N.
　Differential effects of fibroblast growth factor-4, epidermal growth factor and transforming growth factor-beta1 on functional development of stromal layers in acute myeloid leukemia.
Yamada T, Nishino S, Takubo T, Hino M, Kitagawa S, Tatsumi N.
　Simple high-density lipoprotein cholesterol assay based on dry chemistry.
Takubo T, Kanashima H, Terada Y, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Clinical significance of serum E-cadherin levels in patients with haematological malignancies.
Takubo T, Kanashima H, Terada Y, Shibata H, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane Y, Hino M, Ohta T, Hashimoto S, Kamitani T, Tatsumi N, Kumamoto K, Kannagi R
　Analysis of E-selectin mRNA on leukemia cells: a report on two patients with acute leukemia and one patient with lymphoma leukemia accompanied by high serum E-selectin levels.
Medical Postgraduates 2002;40:78-81
Takubo T, Makita K, Shima E, Yamamura R, Aoyama Y, Nakamae H, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi T
　Serum soluble Fas levels in patients with various haematologic malignancies.
Medical Postgraduates 2002;40:65-7
Takubo T, Terada Y, Nakamae H, Aoyama Y, Yamamura R, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N:
　Clinical usefulness of serum IL-18 level determination in patients with haematologic malignancies. 　
J Tumor Marker Oncol 2002;17:25-7
Takubo T, Kanashima H, Terada Y. Shibata H, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N
　Diagnostic value of serum E-cadherin levels in patients with haematologic malignancies.
J Tumor Marker Oncol 2002;17:17-23
Takubo T, Terada Y, Nakamae H, Aoyama Y, Yamamura R, Tanaka K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi T
　Clinical significance of serum soluble transferrin receptor levels in haematologic malignancies.
J Tumor Marker Oncol 2002;17:13-5
Fukumori T, Ohta H, Okubo A, Hino M, Ohta K, Yamane T, Tatsumi N.
　New compact-type latex photometric immunoassay system for hemoglobin and three acute inflammation markers: neutrophil count, C-reactive protein, and anti-streptolysin O.
Yamamura R, Yamane T, Hino M, Ohta K, Shibata H, Tsuda I, Tatsumi N.
　Possible automatic cell classification of bone marrow aspirate using the CELL-DYN 4000 automatic blood cell analyzer.
山根孝久、青山泰孝、中前博久、山村亮介、島　悦子、牧田香理、田中一巨、太田健介、
巽　典之、日野雅之
　造血器悪性腫瘍に対する骨髄非破壊的造血幹細胞移植.
Biotherapy 2002;18:165-70
Aoyama Y, Yamane T, Hino M, Ohta K, Suzuki K, Kitagawa S, Masuyama J, Tatsumi N.
　A novel cell surface antigen, 4C8, is expressed on human eosinophils.
Takubo T, Shibata H, Terada Y, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane T, Hino M, Hashimoto S, Kamitani T, Tatsumi N.
　Serum sialyl Lewis(x) levels in patients with various haematologic malignancies.
Takubo T, Shibata H, Terada Y, Aoyama Y, Nakamae H, Yamamura R, Shima E, Makita K, Tanaka K, Ohta K, Yamane T, Hino M, Hashimoto S, Kamitani T, Tatsumi N.
　Analysis of serum Sialyl-Lewis(x) antigen levels in acute leukemias, myelodysplastic syndromes, myeloproliferative disorders and malignant lymphomas.

 2001
Takubo T, Kumura T, Nakamae H, Aoyama Y, Koh K R, Ohta K, Yamane T, Hino M, Kanashima H, Kamitani T, Ohta T, Kuwajima S, Tatsumi N.
　Urinary trypsin inhibitor levels in the urine of patients with haematological malignancies.
Takubo T, Kumura T, Kanashima H, Nakao T, Nakamae H, Aoyama Y, Yamamura R, Ohta T, Koh KR, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Analysis of IL-18 bioactivity and IL-18 mRNA in three patients with adult T-cell leukaemia, acute mixed lineage leukaemia, and acute lymphocytic leukaemia accompanied with high serum IL-18 levels.
Takubo T, Kumura T, Nakao T, Nakamae H, Aoyama Y, Kinoshita Y, Koh KR, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Expression of human interleukin-18 antigen in leukemia cells in a patient with acute mixed lineage leukemia.
Takubo T, Kumura T, Yamamura R, Nakamae H, Y. Aoyama, Nishiki s, Kinoshita Y, Hashimoto S, Fujino H, Hirose A, Koh KR, Ohta K, Yamane T, Hino M, Kamitani T, Ohta T, Tatsumi N.
　Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, hepatocyte growth factor, interleukin-18 and KL-6 levels in patients with haematologic malignancies.
Medical Postgraduates 2001;39:509-15
Tsuji R, Tatsumi N, Hino M, Nishioka T, Takubo T.
　Tissue factor pathway inhibitor as a universal anticoagulant for use in clinical laboratory tests.
Yokota M, Hino M, Tatsumi N, Nishioka T, Tsuda I.
　RNA extraction from ethanol-fixed leukocytes trapped on polyethylene terephthalate filter for RT-PCR analysis.
Takubo T, Kumura T, Nakao T, Nakamae H, Aoyama Y, Nishiki S, Kinoshita Y, Koh KR, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Serum KL-6 levels in haematologic malignancies and their clinical application.
太田健介、山根孝久、日野雅之、高　起良、中尾隆文、久村岳央、赤堀美佳、金島　広、坂本恵利奈、萩原潔通、田窪孝行、巽　典之
 易感染宿主15例における血液検体に対する真菌PCR法を加えた真菌症補助診断法の検討.
日野雅之、巽　典之
　急性骨髄性白血病の維持強化療法と外来におけるG-CSF（filgrastim）皮下投与の評価
新薬と臨床 2001;50:543-7

2000
Takubo T, Ohkura H, Kumura T, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Serum IL-18 levels in patients with various hematological disorders.
Kumura T, Hino M, Yamane T, Tatsumi N.
　Argatroban as an anticoagulant for both hematologic and chemical tests.
Takubo T, Yamane T, Hino M, Ohta K, Koh KR, Tatsumi N.
　Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura.
Takubo T, Kumura T, Nakao T, Nakamae H, Aoyama Y, Nishiki S, Kinoshita Y, Koh KR, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
 Comparative study on complete remission rate and overall survival in three groups classified based on the serum interleukin-18 level in non-Hodgkin's lymphoma patients.
Takubo T, Kumura T, Nakao T, Nakamae H, Aoyama Y, Nishiki S, Kinoshita Y, Koh KR, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies.
山根孝久、日野雅之、太田健介、高　起良、中前博久、青山泰孝、太田忠信、岸田卓也、麦谷安津子、三宮祐一、紙谷富夫、田窪孝行、巽　典之:
　非Hodgkinリンパ腫に対する自家末梢血幹細胞移植併用大量化学療法.
Kinoshita Y, Ohta K, Yamane T, Hino M, Takubo T, Samori T, Tatsumi N
　Synthetic polymer sulphonated polyisoprene as a universal anticoagulant for laboratory testing.
太田忠信、武岡康信、赤堀美佳、岸田卓也、太田健介、山根孝久、日野雅之、田窪孝行、巽　典之
　近年増加している真菌症の市中病院での原因菌種の変遷と治療の現状.
大阪医学 2000;34:94-6
太田健介、平山栄一、伊藤英樹、田窪孝行、日野雅之、山根孝久、岩井隆子、朴　勤植、巽典之
　総合診療科の外来患者における心身医学的背景に関する検討.
大阪医学 2000;34:43-6
日野雅之、山根孝久、太田健介、田窪孝行、青山泰孝、中前博久、木下喜光、武岡康信、藤野裕子、廣瀬朝生、伊藤聖巳、中村敏子、松本和子、巽　典之
　血液内科通院中の患者のインフォームドコンセントに関するアンケート調査.
大阪医学 2000;34:38-42
Nathalang O, Tatsumi N, Hino M, Yamane T, Sriphaisal T.
　HLA class II alleles in Japanese patients with non-Hodgkin's lymphoma.
Hino M, Tatsumi N, Yamane T, Ohta K, Takubo T, Yabuuchi M.
　New enzymatic method for determining D-arabinitol in serum.
山根孝久、日野雅之、太田健介、高　起良、太田忠信、青山泰孝、阪本親彦、中前博久、長谷川太郎、山村亮介、岸田卓也、田窪孝行、巽　典之
　当科における急性白血病に対する造血幹細胞移植の臨床的検討.
大阪市医学会雑誌 2000;49:191-9
Hino M, Suzuki K, Yamane T, Sakai N, Kubota H, Koh KR, Ohta K, Hato F, Kitagawa S, Tatsumi N.
　Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells.
Narita M, Hino M, Takubo T, Tatsumi N.
　Analogues of ethylenediaminetetraacetic acid and sodium fluoride as anticoagulants.
Kawamoto T, Hino M, Takubo T, Tatsumi N.
　Low-molecular-weight heparin as a multipurpose anticoagulant for laboratory testing.
Kirihigashi K, Tatsumi N, Hino M, Yamane T, Ohta K.
　Basic and clinical evaluation of a newly-developed enzymatic bilirubin assay.
Takubo T, Kumura T, Nishiki S, Kinoshita Y, Koh K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
Takubo T, Okura H, Kumura T, Nishiki S, Kinoshita Y, Koh K, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels.
Yamamura R, Yamane T, Hino M, Ohta K, Koh KR, Tsuda I, Takubo T, Tatsumi N
　Automated bone marrow analysis using the CD4000 automated haematology analyzer.
Kumura T, Hino M, Yamane T, Tatsumi N
　Hirudin as an anticoagulant for both haematology and chemistry tests.
Ota T, Ota K, Hino M, Yamane T, Kishida T, Tatsumi N.
　A practical quick staining method using hydrochloric acid-fast metachromatic dye for megakaryocytes.
Kumura T, Hino M, Yamane T, Tominaga K, Tatsumi N.
　DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant for blood collection tubes.
Nakamae H, Tsumura K, Hino M, Hayashi T, Tatsumi N.
　QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide.
Takubo T, Ohkura H, Kumura T, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels.
Hino M, Ishiko O, Honda KI, Yamane T, Ohta K, Takubo T, Tatsumi N.
　Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery.

1999
Takubo T, Tatsumi N
　Microscopic co-distributions of myosin, actin, α-actinin and vinculin in human neutrophils during movement.
Tatsumi N, Hino M, Nakamura H, Tsuda I, Kondo H.
　Current status of liver function tests in Japan.
Tatsumi N, Takubo T, Tsuda I, Hino M, Ohta K, Yamane T, Kondo H.
　Incidence of abnormalities in laboratory tests found in surveillance of adults over 40 years of age.
Ohta K, Yamane T, Koh KR, Ohta T, Nakamae H, Takubo T, Hino M, Tatsumi N.
　An effective method for recovering CD34 positive progenitor cells from peripheral blood stem cell apheresis products cryopreserved with simplified method.
Koh KR, Yamane T, Ohta K, Hino M, Takubo T, Tatsumi N.
　Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non-neoplastic thrombocytopenic disorders.
Nathalang O, Tatsumi N, Hino M, Prayoonwiwat W, Yamane T, Suwanasophon C, Sriphaisal T.
　HLA class II polymorphism in Thai patients with non-Hodgkin's lymphoma.
Takubo T, Hino M, Suzuki K, Tatsumi N.
　Relative distribution of myosin, actin, and alpha-actinin in adherent monocytes.
Takubo T, Ohkura H, Kumura T, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.
　Serum soluble Fas ligand and soluble Fas levels in hematological disorders.
Medical Postgraduates 1999;37:232-4
Tsuda I, Hino M, Takubo T, Katagami T, Kubota H, Kawai S, Tatsumi N.
　First basic performance evaluation of the XE-2100 haematology analyzer.
J Autom Method Manag Chem 1999;21:127-133
Takubo T, Koh KR, Ohkura H, Kumura T, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N, Hikawa A.
　Serum soluble transferrin receptor level at FAB classification of acute leukemias.
Medical Postgraduates 1999;37:139-41
Sakamoto C, Yamane T, Ohta K, Hino M, Tsuda I, Tatsumi N.
　Automated enumeration of cellular composition in bone marrow aspirate with the CELL-DYN 4000 automated hematology analyzer.
北橋　繁、久保田　浩、松井　正、太田健介、山根孝久、日野雅之、巽　典之
　ELISA-F750のHBs AgおよびHbe Agで非特異反応を示した症例.
日本臨床検査自動化学会会誌 1999;24:120-3
太田忠信、神元章雄、小林　亮、岸田卓也、太田健介、山根孝久、日野雅之、巽　典之
　高齢者に多い慢性疾患に伴う貧血と治療の問題点.
大阪医学 1999;33:8-12

1998
Takubo T, Tatsumi N, Tsuda I, Kasuya K, Taniguchi Y, Fujita T, Uchida K, Matsuo Y, Hayashi T
　Reference values for bisphosphoglycerate mutase protein content and specific activity in human erythrocytes.
Takubo T, Tsuda I, Tatsumi N, Kasuya K, Taniguchi Y, Fujita T, Uchida K, Matsuo Y, Hayashi T.
　An enzyme-linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes.
西木さおり、日野雅之、山根孝久、太田健介、田窪孝行、巽　典之、北川誠一
　好中球の活性酸素産生に対する放射線照射の影響.
医学と生物学 1998;137(5):159-62
太田忠信、岸田卓也、長谷川太郎、平井　学、山根孝久、日野雅之、巽　典之
　一般病院での自家末梢血幹細胞移植の施行経験とその臨床的検討.
Tatsumi N, Tsuda I, Takubo T, Hino M, Imai T, van Hove L.
　Method to evaluate an automated slide maker and stainer system tested on the CELL-DYN SMS.
Lab Hematol 1998;4:58-63
Takubo T, Hino M, Suzuki K, Tatsumi N.
　Localization of myosin, actin, alpha-actinin, tropomyosin and vinculin in surface-activated, spreading human platelets.
Yamane T, Hino M, Ohta K, Nakao T, Nakamae H, Yamamura R, Takubo T, Tatsumi N.
　Peripheral blood stem cell transplantation for non-Hodgkin's lymphoma in complete remission.
Takubo T, Yamane Y, Hino M, Hashimoto S, Koh KR, Sakamoto C, Kamitani T, Tatsumi N, Hikawa A.
　The value of serum soluble transferrin receptor (sTfR) determination in hematological malignancies.
Nakao T, Hino M, Yamane T, Nishizawa Y, Morii H, Tatsumi N.
　Expression of the leptin receptor in human leukaemic blast cells.
Takubo T, Hino M, Tatusmi N
　Localization of myosin, actin, and α-actinin in surface-activated, spresding human platelets.
J Anal Bio-Sci 1998;73:155-7
Aoyama Y, Yamane T, Ohta K, Hino M, Tatsumi N.
　Study on the measurement of the percentage of viable cells in frozen peripheral blood stem cell harvesting samples by an automated hematology analyzer.
Takubo T, Hino M, Suzuki K, Tatsumi N.
　Relative distribution of myosin, actin and alpha-actinin in surface-activated, spreading platelets.
Takekawa K, Yamane T, Hino M, Tatsumi N.
　Determination of hematopoietic stem cells in peripheral blood by an automated hematology analyzer (SE-9000).
Takubo T, Hino M, Suzuki K, Tatsumi N.
　Microscopical localization of actin-associated proteins alpha-actinin, tropomyosin and vinculin in motile human neutrophils.
Takubo T, Yamane T, Hino M, Tsuda I, Tatsumi N.
　Usefulness of determining reticulated and large platelets in idiopathic thrombocytopenic purpura.
Hirai N, Tatsumi N, Hino M, Yamane T, Ohta K.
　Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
橋本卯巳、日吉基文、田窪孝行、田川進一、巽　典之
　Amplicor CMV PCRキットで得られるPCR増幅産物を電気泳動法で確認するための至適条件の検討
Jpn J Electroph 1998;42:181-4
西木さおり、日野雅之、山根孝久、太田健介、田窪孝行、巽　典之、北川誠一
　好中球の活性酸素産性に対する放射線照射の影響
医学と生物学 1998;137:159-62

1997
Takekawa K, Yamane T, Suzuki K, Hino M, Tatsumi N.
　Identification of hematopoietic stem cells by the SE-9000 automated hematology analyzer in peripheral blood stem cell harvest samples.
Takubo T, Tatsumi N.
　Distribution of myosin and actin in moving human neutrophils detected by double-fluorescence staining.
Takubo T, Yamane T, Tsuda I, Tagawa S, Tatsumi N.
　Polymorphonuclear neutrophils in saliva and blood: a comparative study of morphology, function and phenotype.
Yamane T, Hino M, Tatsumi N.
　Change in FAS antigen expression during differentiation of CD34-positive cells isolated from peripheral blood stem cell harvest samples.
Hasuike T, Hino M, Yamane T, Nishizawa Y, Morii H, Tatsumi N.
　Effects of TNP-470, a potent angiogenesis inhibitor, on growth of hematopoietic progenitors.
Takubo T, Tatsumi N.
　Dual image of myosin and actin in human neutrophils during movement by fluorescence microscopy.
Takubo T, Tatsumi N.
　The intracellular distribution patterns of myosin and actin are different among human neutrophils and monocytes during locomotion.
Hashimoto S, Hiyoshi M, Ohta T, Ohta K, Aoyama Y, Takubo T, Tagawa S, Tatsumi N.
　The utility of measuring prothrombin fragment F1+2 in monitoring minimal hypercoagulation in patients with hematopoietic malignancies.
Laboratory Hematology 1997;3:27-30
Koh KR, Yamane T, Ohta K, Hino M, Tatsumi N.
　Change in reticulated platelet count before and after leukocyte removal filtration for platelet concentrate transfusion.
Laboratory Hematology 1997;3:316-8
Ohta T, Tatsumi N, Kishida T.
　Discrimination of iron deficiency anemia from other anemia by multiple discriminant analysis of routine blood count and red cell distribution width.
Hasuike T, Hino M, Yamane T, Tatsumi N.
　In vitro expansion of mature neutrophils from isolated peripheral blood stem cells.
田窪孝行、桑島士郎、巽　典之
　ヒト尿中トリプシンインヒビターの造血器腫瘍性疾患における臨床的有用性
医学と生物学 1997;134:25-8
高　起良、山根孝久、日野雅之、巽　典之
　造血器悪性腫瘍疾患に対する化学療法後の網血小板比率と白血球数の推移
医学と生物学 1997;134:165-8
田窪孝行、高　起良、蓮池孝夫、紙谷富夫、和泉良仁、桑島士郎、巽　典之
　造血器疾患における尿中トリプシンインヒビター活性
医学と薬学 1997;37:453-5
中前博久、日野雅之、山根孝久、巽　典之
　大阪地区におけるサラセミアの検討
大阪医学 1997;31:39-43
中　恵一、巽　典之、中野幸弘、吉本　茂
　尿酸測定用液状試薬「ウリカラー・リキッドS」の評価
現代医療 1997;29(増刊 I):521-7
橋本卯巳、日吉基文、太田健介、日野雅之、山根孝久、太田忠信、高　起良、田窪孝行、田川進一、巽　典之
　造血器悪性腫瘍に対する化学療法時における各種の凝固線溶系マーカーおよびプロトロンビンフラグメントF1+2の測定意義
生物試料分析 1997;20:303-6

1996
麥谷安津子、山根孝久、朴　勤植、任　太性、巽　典之
　末梢血幹細胞移植を併用した大量化学療法に合併した心合併症の検討.
日本癌治療学会雑誌 1996;31(4):255-262

1995
Hiyoshi M ,Yamane T, Hirai M, Harroti H, Nakao Y, Yasui Y, Koh K-R, Hino M, Tatsumi N.
　Establishmment and characterization of IRTA17 and IRTA21 two novel acute non-lymphocytic leukaemia cell lines with t(16;21) translocation.
Yamane T, Takekawa K, Tstsumi N.
　Possibility of identification of hematopoietic stem cells using a conventional blood cell counter.
Hino M, Nishizawa K, Tagawa S, Yamane T, Morii H, Tatsumi N.
　Constitutive expression of the thrombopoietin gene in a human hepatoma cell line.
Yamane T, Hino M, Park K, Im T, Tatsumi N, ON Thalang.
　c-kit-positive cells and CD34-positive cells in cryopreserved peripheral blood stem cell samples.
山根孝久、久村岳央、中尾隆文、朴　勤植、任　太性、巽　典之
　造血器悪性腫瘍に対する自家末梢血幹細胞移植.
大阪市学会雑誌 1995;44(1):23-31

1994
山根孝久、日野雅之、麦谷安津子、朴　勤植、任　太性、橋本卯巳、太田忠信、高　起良、巽　典之
　CD34陽性細胞数を造血回復の指標とした末梢血幹細胞移植の試み.
BIOTHERAPY 1994;8(11):1453-1456
Im T, Yamane T, Mugitani A, Hiyoshi M, Park K, Tatsumi N.
　Treatment with cytosine arabinoside and granulocyte colony-stimulating factor in patients with myelodysplastic syndrome and its leukemic patients.
山根孝久、太田忠信、高　起良、橋本卯巳、竹川勝宏、平井信光、田中一巨、蓮池孝夫、平井　学、太田健介、大平秀公、中尾吉孝、安井良則、日吉基文、日野雅之、佐々木安津子、朴　勤植、任　太性、巽　典之
　造血器悪性腫瘍に対する自家末梢血幹細胞移植を併用したRanimustine,Cytarabine,EtoposideおよびCyclophosphamide併用療法の治療成績.
Yamane T, Park K, Im T, Tatsumi N.
　Detection of the granulocyte colony stimulating factor receptors on human leukemic cells.
Hematology Reviews and Commun 1994;8:195-200

1993
Inoue T, Yamane T, Park K, Im T, Tatsumi N, Okuda K.
　Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
平井　学、竹川勝宏、平井信光、蓮池孝夫、進藤喜予、太田健介、安井良則、中尾吉孝、大平秀公、井上　健、古川佳央、山根孝久、佐々木安津子、朴　勤植、任　太性
　recombinant human G-CSF投与による末梢血幹細胞採取法の検討.
日本輸血学会雑誌 1993;39(6):997-1001
Yamane T, Im T, Tatusmi N, Okuda K.
　Flow cytometric analaysis of G-CSF receptors on normal white blood cells and leukemic cells.
任　太性、竹川勝宏、蓮池孝夫、田中一巨、平井　学、簾　喜予、太田健介、中尾吉孝、大平秀公、安井良則、古川佳央、井上　健、山根孝久、朴　勤植、巽　典之、岸田卓也、佐々木安津子、橋本孝二、巽　陽一
　造血器疾患に伴う抗生剤不応性発熱例に対するミコナゾールの臨床的検討.
新薬と臨床 1993;42(3):574-579
Tatsumi N, Yamane T, Tsuda I, Okuda K, Chaisiripoomkere W.
　Flow cytometric detection of recombinant human granulocyte colony stimulating factor binding to leukemic cells.

1992
井上　健、山根孝久、古川佳央、安井良則、太田健介、中尾吉孝、大平秀平、田中一巨、蓮池孝夫、平井　学、簾　喜予、朴　勤植、任　太性、巽　典之、奥田　清
　組織球増殖性疾患の臨床像および細胞像と予後に関する検討.
山根孝久、田中一巨、蓮池孝夫、平井　学、簾　喜予、太田健介、大平秀公、中尾吉孝、安井良則、井上　健、古川佳央、朴　勤植、任　太性、巽　典之、奥田　清、佐々木安津子、岸田卓也
　血液疾患に併発した感染症に対するFlomoxefとTobramycinの併用療法の治療成績.
朴　勤植、任　太性、山根孝久、古川佳央、井上　健、大平秀公、太田健介、安井良則、中尾吉孝、簾　喜予、田中一巨、平井　学、蓮池孝夫、岸田卓也、佐々木安津子、巽　典之、川合清毅
　悪性リンパ腫に対するNK171s（エトポシド小型化硬カプセル剤）の使用経験.
基礎と臨床 1994;26(3):236-241
岸田卓也、三宮祐一、中尾吉孝、安井良則、太田健介、大平秀公、井上　健、古川佳央、山根孝久、朴　勤植、任　太性、巽　典之
　造血器疾患及び胃癌に合併した重症感染症に対するPanipenem/Betamipronの臨床的検討.

1991
山根孝久、井上　健、古川佳央、安井良則、太田健介、中尾吉孝、大平秀公、田中一巨、蓮池孝夫、平井　学、簾　喜予、朴　勤植、任　太性、巽　典之、奥田　清、久保田　浩、片上伴子、北橋　繁
急性非リンパ性白血病におけるCD56抗原の発現.
Park K, Im T, Yamane T, Nakao Y, Yasui Y, Ohta K, Ohira H, Inoue T, Furukawa Y, Hiyoshi M, Kishida T, Tatsumi N, Okuda K, Nishio S.
　Positive effect of granulocyte-colony stimulating factor on erythropoiesis in humans.
Inoue T, Furukawa Y, Yamane T, Hiyoshi M, Sasaki A, Kishida T, Park K, Im T, Tatsumi N, Okuda K.
　Therapy with mitoxantrone, ifomide, vindesine, and predonisolone for malignant lymphoma with adjustable doses and timing of courses.
Hiyoshi M, Ymane T, Inoue T, Furukawa Y, Tatsumi N.
　Anti-gelsolin antibody for detection of plasma and platelet gelsolin.
山根孝久、井上　健、古川佳央、巽　典之、奥田　清
 当科における急性骨髄性白血病73症例の臨床的検討.
大阪市医学会雑誌 1993;40(1):123-134
井上　健、太田健介、大平秀公、中尾吉孝、安井良則、古川佳央、山根孝久、日吉基文、佐々木安津子、岸田卓也、朴　勤植、任　太性、巽　典之
　造血器悪性腫瘍化学療法時におけるRecombinant Human Granulocyte Colony Stimulating Factor(rhG-CSF)の効果.

1990
山根孝久、中尾吉孝、安井良則、太田健介、大平秀公、井上　健、古川佳央、日吉基文、佐々木安津子、岸田卓也、朴　勤植、任　太性、巽　典之、奥田　清
　血液疾患に合併した感染症に対するCefmetazoleとNetilmicinの併用療法の治療成績.
Yamane T, Nakao Y, Yasui Y, Ohta K, Ohira H, Inoue T, Furukawa Y, Hiyoshi M, Sasaki A, Kishida T, Park K, Im T, Tatsumi N, Okuda K, Tatsumi J, Tatsumi Y, Hashimoto K, Sannomiya Y.
　Evaluation of 117 patients with non-Hodgkin's lymphoma in the past ten years at our department.
Im T, Furukawa Y, Inoue T, Ymanae T, Hiyoshi M, Kishida T, Sasaki A, Park K, Tatsumi N, Okuda K.
　Evaluation of Serum Sialyl LewisX-i in Hematologic disorders.
佐々木安津子、井上　健、古川佳央、山根孝久、日吉基文、岸田卓也、朴　勤植、任　太性、巽　典之
　慢性ITPにおけるシクロスポリン療法の臨床的有用性の検討.
井上　健、太田健介、大平秀公、中尾吉孝、安井良則、古川佳央、山根孝久、日吉基文、岸田卓也、佐々木安津子、朴　勤植、任　太性、巽　典之
　ITPに対する免疫グロブリン療法および摘脾時における血小板容積の変動.
基礎と臨床 1990;24(13):635-639
巽　典之、任　太性、山根孝久、赤坂清司、安永幸二郎、藤竹英樹、岸本裕司、蔭山　克、大薮　博、木谷照夫、徳嶺進洋、正岡　徹、平岡　諦、川越裕也、平田充彦、米澤穀、西浦哲雄、堀内　篤、椿　和央、永井清保、金丸昭久
　サイメリンの慢性骨髄性白血病に対する使用経験.
臨床と研究 1990;66(9):280-282
任　太性、古川佳央、井上　健、山根孝久、佐々木安津子、岸田卓也、朴　勤植、巽　典之
　特発性血小板減少性紫斑病に対するガンマグロブリン大量療法の有効な投与法の検討.
大阪市医学会雑誌 1990;39(2):491-496

1989
巽　陽一、橋本孝二、巽　純子、井上　健、古川佳央、山根孝久、日吉基文、佐々木安津子、岸田卓也、朴　勤植、任　太性、巽　典之
　FK-840の鉄欠乏性貧血および鉄欠乏状態に対する臨床効果.
薬理と治療 1989;18(1):207-211
山根孝久、井上　健、古川佳央、佐々木安津子、岸田卓也、朴　勤植、任　太性、巽　典之
　急性白血病に対するMB-triple V療法の検討.
山根孝久、井上　健、古川佳央、日吉基文、佐々木安津子、岸田卓也、任　太性、巽　典之、奥田　清
　慢性骨髄増殖性疾患に対するMCNUの治療成績.
新薬と臨床 1989;38(10):1784-1790
山根孝久、井上　健、古川佳央、日吉基文、佐々木安津子、岸田卓也、任　太性、巽　典之、奥田　清
　Two color分析による成人T細胞白血病細胞の検討.
山根孝久、井上　健、古川佳央、日吉基文、佐々木安津子、岸田卓也、任　太性、巽　典之、奥田　清
　血液疾患に合併した感染症に対する抗生物質の治療成績（第2報）-Imipenem/Cilastatin sodium(IMP/CS)による治療-.
大阪市医学会雑誌 1989;38(3):573-578
Sasaki A, Inoue T, Furukawa Y, Yamane T, Hiyoshi M, Kishida T, Im T, Tatsumi N, Okuda K.
　Clinical study of malignant lymphoma of head and neck in the nasal cavity and Waldyer's ring.
佐々木安津子、井上　健、古川佳央、山根孝久、日吉基文、岸田卓也、任　太性、巽　典之
　Myelodysplastic Syndromeに対するウベニメクス(ベスタチン)投与の試み.
BIOTHERPY 1989;3(2):573-577
山根孝久、井上　健、古川佳央、日吉基文、佐々木安津子、岸田卓也、任　太性、巽　典之、奥田　清
　血液疾患に合併した感染症に対する抗生物質の治療成績(第1報)-Flomoxef(FMOX)による治療-.
大阪市医学会雑誌 1989;38(1):129-134
佐々木安津子、井上　健、古川佳央、山根孝久、日吉基文、岸田卓也、任　太性、巽　典之、奥田　清、田中庸隆、松井　正
　造血器腫瘍に伴う真菌感染症に対するカンジダ抗体価による経過追跡.
Therapeutic Research 1989;10(1):147-158

1988
Im T, Inoue T, Furukawa Y, Yamane T, Hiyoshi M, Sasaki A, Kishida T, Kojima K, Yoshikawa T, Sannomiya Y, Tatsumi N.
　Evaluation of bone marrow involvement of malignant lymphoma by bone marrow aspiration and biopsy: Necessity to evaluate both samples together.
橋本孝二、巽　陽一、古川佳央、井上　健、山根孝久、日吉基文、佐々木安津子、岸田卓也、朴　勤植、任　太性、巽　典之
　特発性血小板減少性紫斑病に対する1回投与法による免疫グロブリン大量療法.
大阪市医学会雑誌 1988;37(4):1039-1043
佐々木安津子、井上　健、古川佳央、山根孝久、左川　均、岸田卓也、三宮祐一、任　太性、巽　典之
　成分献血ドナーの確保-血液疾患患者周辺を通じてのアプローチ-.
臨床血液 1988;29(11):2169-2171
日野雅之、三木隆巳、西沢良記、森井浩世、中塚喜義、田畑　勉、聴涛貴一郎、松下義樹、井上　隆
　透析患者の貧血　1.施設における実態.
臨床透析 1988;4:31-32

1987
Hashimoto K, Im T, Hiyoshi M, Yamane T, Furukawa Y, Inoue T, Tatsumi N.
　Accerelation of actin polymerization by actin-coated latex pertcles.
任　太性、山根孝久、左川　均、日吉基文、岸田卓也、佐々木安津子、横松泰夫、小嶋和英、三宮祐一、吉川岳男、巽　純子、橋本孝二、巽　典之、奥田　清
　Jamshidi生検針を用いた骨髄生検による癌骨髄転移の検討.
横松泰夫、左川　均、山根孝久、日吉基文、佐々木安津子、岸田卓也、小嶋和英、吉川岳男、三宮祐一、瓦林佳子、任　太性、巽　典之、橋本孝二、巽　陽一、紙谷富夫、巽　純子、朴　勤植
　初回治療急性白血病に対する”B-Triple V”療法の検討.
Tatsumi N, Niri M, Frukawa Y, Inoue T, Sagawa H, Yamane T.
　Determination of ATP relewase of human platelets using collagen sepharose resin.
三宮祐一、山根孝久、左川　均、日吉基文、横松泰夫、佐々木安津子、岸田卓也、小嶋和英、吉川岳男、巽　純子、橋本孝二、瓦林佳子、任　太性、巽　典之、奥田　清、朴　勤植
　悪性リンパ腫におけるMCOP療法の試み.

トップへ
戻る